VIS Quiz Question #3

The FDA's decision was based on data from the pivotal phase 3 RENOIR trial, which demonstrated the efficacy, immunogenicity, and safety of Abrysvo in adults aged ≥60 years.

Expert primary care physicians discuss a study on the use of the KidneyIntelX test in patients with diabetic kidney disease (DKD). They discuss the practical and clinical implications of the risk assessment capabilities of the test to improve screening and health outcomes for patients at risk for progressive kidney failure related to DKD.

Researchers found a total of 12 symptoms that contributed to the long COVID scoring system.

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

Menstrual migraine is often described as more disabling than non-menstrual migraine. Get an overview and test your knowledge, here.

The FDA approved Paxlovid™ for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe disease.